AKR1B1 and diabetes mellitus: The polyol pathway enzyme aldose reductase is associated with diabetes, making it a possible therapeutic target.<h4>Methods</h4>By redocking the co-crystallised ligand sulindac sulfone into the aldose reductase binding site, the researchers proved the docking approach's reliability with a 0.117 Å root mean square deviation (RMSD).